November 11, 15:00 CET | Online
Join our virtual event to find out how advances in whole genome sequencing have brought newfound insights into rare disease analysis.
More than 300 million people world-wide and an estimated 6% of the population are affected by rare disease. Currently there are >6000 known rare diseases, 80% have a known genetic etiology, 50% affecting children under the age of five and 4.5% of children present annually with a genetic condition. WGS offers the opportunity to shorten the diagnostic odyssey and is broadly accepted to become standard of care for rare diseases. It also has the ability to detect many variant classes simultaneously allowing for a much more thorough investigation of the genomic context of disease.
For Research Use Only. Not for use in diagnostic procedures (except as specifically noted).
